版本:
中国

BRIEF-Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients

Nov 21 Rosetta Genomics Ltd :

* Rosetta genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐